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Protected carotid-artery stenting versus endarterectomy in high-risk
patients
Yadav JS, Wholey MH, Kuntz RE, et al. New Engl J Med 2004;351:1493-
501.
Conclusion: Carotid stenting with the use of an emboli-protection
device is not inferior to carotid endarterectomy for treatment of severe
carotid artery stenosis in patients considered at high risk for carotid endar-
terectomy.
Summary: This is a long awaited publication of the Stenting and
Angioplasty with Protection in Patients at High Risk for Endarterectomy
(SAPPHIRE) trial. The authors conducted a randomized trial comparing
carotid artery stenting with an emboli-protection device versus carotid
endarterectomy in 334 patients with coexisting medial or anatomic condi-
tions that may increase the risk of carotid endarterectomy. Patients included
in the trial had at least 50% symptomatic carotid artery stenosis, or if the
lesion was asymptomatic, a stenosis of at least 80%. The primary end point
was somewhat unusual in that it consisted of cumulative incidents of
cardiovascular events in 1 year. These included a composite of death, stroke,
or myocardial infarction within 30 days after the intervention, or death or
ipsilateral stroke between 31 days and 1 year. Recurrent carotid stenosis was
not an end point.
The primary end point occurred in 20 patients assigned to the carotid
stenting with an embolic-protection device group (cumulative incidence,
12.2%) and in 32 patients who underwent carotid endarterectomy (cumu-
lative incidence, 20.1%; absolute difference, 7.9% ; 95% confidence inter-
val, 16.4% to 0.7%; P  .004 for non-inferiority, and P  .053 for
superiority). In this study, approximately 20% of the patients were80 years
old and 22%were entered for recurrent carotid stenosis. Less than 30% of the
patients had symptomatic stenosis. There were no differences in the cumu-
lative incidence of the primary end point at 1 year in the patients with
symptomatic stenosis (16.8% among those who received a stent vs 16.5%
among those who underwent endarterectomy, P  .95). For patients with
asymptomatic carotid stenosis, the cumulative incidence of the primary end
point at 1 year was lower among those who received a stent (9.9%) than
among those that underwent carotid endarterectomy (21.5%), P  .02.
Comment:This study, first published inUSAToday, has now appeared
in theNew England Journal of Medicine. The differences in the primary end
points between the endarterectomy and stented group appear to be primarily
driven by the higher number of myocardial infarctions, primarily non-Q
wavemyocardial infarctions, in the endarterectomy group. Nearly 75% of the
patients were treated for asymptomatic stenosis. The applicability of the
results of this trial for the overall care of patients with carotid artery disease
seems limited. Given the narrow therapeutic index of intervention for
asymptomatic carotid stenosis, particularly recurrent carotid stenosis, it is
likely the large majority of patients entered into the trial would not have
been, in many practices, suitable candidates for any carotid intervention,
regardless of whether it was endarterectomy or stent.
Late survival after elective repair of aortic aneurysms detected by
screening
Taylor JC, Shaw E, Whyman MR, et al. Eur J Vasc Endovasc Surg 2004:
270-3.
Conclusion: Men who undergo elective repair of an abdominal aortic
aneurysm (AAA) originally detected by screening have better later survival
than men with AAAs discovered incidentally and repaired electively.
Summary:Between 1990 and 1998, 424men underwent elective AAA
repair. Aneurysm repairs were performed for 181 AAAs detected in an
aneurysm screening program and in 243 where the aneurysm was diagnosed
incidentally. Follow-up survival data were collected until 2003. There was a
minimum of 5 years of follow-up.
Postoperative 30-day mortality after AAA repair was lower in men
whose aneurysms were detected by screening (4.4%) compared with those
detected incidentally (9.0%). Similarly, 5-year survival (78% vs 65%) and
10-year survival (63% vs 40%) were better after repair of a screen-detected
AAA than after repair of an AAA detected incidentally (P .0003 at all time
intervals). Patients whose aneurysms were detected incidentally were re-
paired at an older age than those whose aneurysms were detected by a
screening study (71.23 years vs 67.1 years).
Comment: The greater the patient’s potential life span, the greater the
possibility of a procedure to prolong survival. The paper does not necessarily
indicate that aneurysm screening programs increase overall survival. The
paper does indicate that participants in aneurysm screening programs have
their aneurysms repaired at an earlier age and therefore have greater potential
to derive survival benefit from the procedure. The results may also indicate a
greater tendency of younger patients to participate in screening programs
than older patients.
Carotid plaque echolucency increases the risk of stroke in carotid
stenting: The Imaging in Carotid Angioplasty and Risk of Stroke
(ICAROS) study
Biasi GM, Froio A, Diethrich EB, et al. Circulation 2004;110:756-62.
Conclusion: Increased echolucency of carotid artery plaques increases the
risk of stroke associated with carotid artery angioplasty and stenting (CAS).
Summary: This is a report of 418 cases of CAS derived from the the
Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) Registry and
collected from 11 international centers. The authors used high-resolution
B-mode duplex scanners in conjunction with a computer-assisted index of
echogenicity (gray scale median [GSM]) to quantify carotid plaque echolu-
cency. GSMs were classified as25 or25. Neurologic deficits during CAS
and in the postprocedural period were recorded.
Overall, the rate of neurologic complications was 3.6% (major stroke,
1.4%; minor stroke, 2.2%). Eleven strokes occurred in patients whose carotid
plaque GSMs were25 (n 155, 7.1%), and 4 strokes occurred in patients
with GSMs  25 (n  263, 1.5%, P  .005). Patients with 85% carotid
stenosis had a higher rate of stroke (P  .03). Cerebral protection devices
appeared effective in patients with GSMs 25 (P .01) but did not appear
effective in those with GSMs  25. Multivariable analysis indicated that
GSM (odds ratio [OR], 7.11; P .002) and severity of stenosis (OR, 5.76;
P  .010) were independent predictors of stroke.
Comment: The data suggest that patients with more echolucent
plaques and with higher degrees of internal carotid artery stenosis are at
higher risk of neurologic complications with carotid artery stenting. The
embolic potential of soft (echolucent) plaques is obvious to all who have
visualized such plaques at the time of carotid endarterectomy. The authors
also suggest the higher neurologic complication rate in patients with more
severe stenosis may reflect a higher number of embolic particles associated
with crossing a tight lesion with an endovascular device.
A combination of statins and beta-blockers is independently associated
with a reduction in the incidence of perioperative mortality and non-
fatal myocardial infarction in patients undergoing abdominal aortic
aneurysm surgery
Kertai MD, Boersma E, Westerhout CM, et al. Eur J Vasc Endovasc Surg
2004;28:343-52.
Conclusion: A combination of statin and -blocker therapy in patients
undergoing abdominal aortic aneurysm surgery is associated with reduced
perioperative mortality and nonfatal myocardial infarction.
Summary: The authors studied 570 patients who underwent abdom-
inal aortic aneurysm repair between 1991 and 2001. Themean age was 69
9 years and 486 were men. Data were analyzed for clinical risk factors
(history of myocardial infarction, age 70, diabetes mellitus, renal failure,
stroke, pulmonary disease, and heart failure) as well as use of statins and
-blockers and whether they had undergone a dobutamine stress echo test.
The main end point was a composite of perioperative mortality and myocar-
dial infarction within 30 days of surgery.
Myocardial infarction or death occurred in 51 (8.9%) patients. The
incidence of the composite end point was lower in statin users compared
with nonusers (3.7% vs 11.0%, odds ratio [OR], 0.31; 95% confidence
interval [CI], 0.13 to 1.74; P  .01). The benefit for statin use remained
after correcting for covariants. -Blocker use was also associated with
reduction in the composite end point (OR, 0.24; 95% CI, 0.11 to 0.54).
Patients with more severe risk factors appeared to particularly benefit from a
combination of statin and -blocker use.
Comment: It is now well appreciated that -blockers lower perioper-
ative mortality and adverse cardiovascular events in patients undergoing
peripheral vascular surgery. It is also appreciated that statins lower long-term
mortality in patients with peripheral vascular disease. Emerging data such as
these indicate that statin therapy may also have beneficial effects in the
perioperative period as well.
Transient ischemic attacks are more than “ministrokes”
Daffertshofer M, Mielke O, Pullwitt A, et al. Stroke 2004;35:2453-8.
Conclusion: Transient ischemic attacks (TIA) are not so “benign,”
with significant risks of early stroke, death and disability.
Summary: The clinical significance of TIA is controversial. An esti-
mated 4.9 million people in North America do not seek medical attention
despite TIA symptoms (Neurology 2003;60:1429-34). In this study, the
authors compared a large cohort of hospitalized TIA and stroke patients
derived from a stroke quality-assessment study. Prehospital and in-hospital
procedures, symptoms, complications, outcomes, and therapies were de-
rived from a representative sample from stroke-treating hospitals (n 82) in
southwestern Germany. Follow-up was attempted 6 months after discharge.
Points analyzed include death or dependency in activities of daily living as
determined by a modified Rankin scale (mRS) of 3 to 6, Barthel index of less
than 95, or institutionalization in a nursing home.
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The database comprised 1380 TIA patients and 3855 stroke patients.
During hospitalization, stroke incidence was 8% for TIA patients, and an
additional 5% had strokes within 6 months. These figures for ischemic stroke
patients were 7% and 6% respectively (P .05). Two percent of TIA patients
died in the hospital (5% after hospitalization) compared with 9% of stroke
patients (10% after hospitalization, P  .001). Seventeen percent of TIA
patients compared with 38% of ischemic stroke patients (P  .05) were
dependent at follow-up. A pre-existing neurologic deficit (mRS 2) was the
strongest predictor for death or disability (baseline mRS odds ratio, 4.1; 95%
confidence interval, 2.32 to 7.2). The most important and significant
predictors for death or dependency at follow-up in TIA patients were age
greater than 60 years, mRS greater than 2 on admission, a cardiogenic source
of emboli, or a visible infarction on computed tomography or magnetic
resonance imaging.
Comment: The data indicate that hospitalized patients with TIA have
a better outcome than hospitalized patients with stroke. Nevertheless, the
risk for death or disability is still quite remarkable in the TIA patients. TIA
patients should be treated in a manner similar to acute stroke patients with
respect to urgency of evaluation and institution of appropriate therapy.
Upper-extremity deep vein thrombosis: a prospective registry of 592
patients
Joffe HV, Kucher N, Tapson VF, et al. Circulation 2004;110:1605-11.
Conclusion: Upper-extremity deep venous thrombosis (UEDVT) risk
factors differ from conventional risk factors for lower-extremity DVT
(LEDVT).
Summary: The authors sought to improve understanding of UEDVT
through a description of 592 patients with UEDVT. Data was derived from
a United States multicenter prospective registry of 5451 patients with
ultrasound-diagnosed DVT. The authors compared demographics, risk
factors, DVT prophylaxis, symptoms, and initial management of patients
with central venous catheter-associated UEDVT and noncentral venous
catheter-associated UEDVT versus patients with LEDVT. Available for
comparison were 324 patients with central venous catheter-associated
UEDVT, 268 patients with noncentral venous catheter-associated UEDVT,
and 4796 patients with LEDVT.
Noncentral venous catheter-associated UEDVT patients were younger
(59.2 18.2 years old vs 64.216.9 years old, P .0001), less often white
(65% vs 73%, P .01), and had a lower body mass index (BMI) (26.8 7.1
kg/m2 vs 28.5  7.3 kg/m2, P  .001). They were also more likely to
smoke (19% vs 13%, P  .02) than LEDVT patients.
An in-dwelling central venous catheter was the strongest independent
predictor of UEDVT (odds ratio, 7.3; 95% confidence interval, 5.1 to 9.2).
A BMI of less than 25 kg/m2, an age younger than 67 years, and hospital-
ization were independent predictors of noncentral venous catheter-
associated UEDVT. Only 20% of 378 UEDVT patients who did not have an
obvious contraindication to anticoagulation had received prophylaxis at time
of diagnosis.
Comment: In addition to the obvious risk factor of a central venous
catheter for production of UEDVT, the authors point out differences
between risk factors for UEDVT and LEDVT. Younger age and lean body
weight, as well as inpatient status, independently predicted UEDVT. The
data suggest possible underlying differences in the pathophysiology of
upper-extremity versus lower-extremity DVT.
Homocysteine levels, haemostatic risk factors and patency rates after
endovascular treatment of the above-knee femoral-popliteal artery
Laxdal E, Eide GE, Wirsching J, et al. Eur J Vasc Endovasc Surg 2004;28:
410-7.
Conclusion: Early restenosis or occlusion after endovascular treatment
of the above-knee femoral-popliteal artery is frequent in patients with
diabetes, elevated d-dimer, in those without antithrombotic therapy after
the procedure, and in patients treated for occlusion rather than stenosis.
Summary: This prospective observational study was conducted at a
university hospital in Norway. The authors investigated the relationship
between hemostatic variables and plasma homocysteine, and restenosis or
occlusion after endovascular treatment of symptomatic femoral-popliteal
lesions. The study comprised 116 limbs and 103 patients. Angioplasty was
subintimal in 58 cases (50%) and intraluminal in 58 cases (50%). Occlusions
longer than 4 cm were treated with subintimal angioplasty, and occlusions
shorter than 4 cm or stenoses were treated with transluminal angioplasty.
Thirty-four percent of patients were treated for critical limb ischemia. Prior
to angioplasty, plasma values were obtained for homocysteine, d-dimer,
fibrinogen, and protein-C resistance.
Median follow-up was 11 months (range, 0 to 42 months). Patients
treated with subintimal angioplasty had follow-up at 1, 3, 6, 9, 12, and 18
months with ankle brachial index (ABI) measurements as well as duplex
ultrasound scans of the treated artery. Patients treated with intraluminal
angioplasty had routine follow-up at 1 and 12 months with ABI measure-
ments and clinical evaluation. Many patients had additional follow-up
because symptoms reoccurred or contralateral disease developed. A reduc-
tion in ABI of more than 10% combined with reoccurrence of symptoms
indicated restenosis or occlusion. Findings were confirmed either by angiog-
raphy or duplex ultrasound scans. End point frequency rates were estimated
with the Kaplan-Meier method. The Cox proportion hazardmodel was used
to assess variables related to patency.
Using the authors’ definition of patency, the 1-year cumulative patency
rate for all procedures was 48%. Limb salvage was 74% in cases of critical limb
ischemia. Homocysteine was higher in the patients with critical limb isch-
emia than in those with claudication alone. Multivariable analysis suggested
significant independent associations between patency rates and plasma d-
dimer, diabetes, nature of the lesion treated (stenosis vs occlusion), and use
of antithrombotic therapy (aspirin) after the procedure. There was no
association with patency among plasma levels of homocysteine, activated
protein-C resistance, or fibrinogen.
Comment: Inconsistent follow-up and no consistent protocol incor-
porating imaging studies of the treated artery are obvious major weaknesses
of this paper. In addition, the mixing of two types of angioplasty techniques
and the mixing of clinical indications are also serious methologic weaknesses
that preclude any definitive conclusions. However, the idea that different
hematologic factors may have variable effects on the outcome of the angio-
plasty is interesting and deserves further study.
Preclinical changes in the mechanical properties of the abdominal aorta
in obese children
Iannuzzi A, Licenziati MR, Acampora C, et al. Metabolism 2004;53:
1243-6.
Conclusion: High-resolution B-mode ultrasound scans can be used to
demonstrate changes in the mechanical properties of the abdominal aorta in
obese children.
Summary: Childhood obesity is associated with the development of
early vascular abnormalities. The authors investigated whether B-mode
ultrasound scanning could be used to detect preclinical functional changes in
the abdominal aorta of obese children. Fifty healthy controls and 100
consecutive obese children were studied. The obese children and controls
were matched in terms of age and gender. B-mode ultrasound scanning was
used to determine the wall motion of the abdominal aorta. The authors then
measured or computed the following mechanical properties: lumen systolic
and diastolic diameters, aortic strain, elastic modulus, and stiffness.Measure-
ments of blood pressure, total cholesterol, triglycerides, insulin, and C-
reactive protein were also obtained.
Compared with controls, obese children had higher concentrations of
total cholesterol, triglycerides, C-reactive protein, insulin, and higher blood
pressure. Homeostasis model assessment (HOMA), a parameter of insulin
resistance, was significantly higher in obese children than in controls (P 
.001). Aortic mechanical parameters were also significantly different in obese
children than in controls, with stiffness (P .001) as well as elastic modulus
(P .001) both being higher in obese children than in controls. Obese girls
in the highest tertile of HOMA had increased aortic stiffness compared to
obese girls in the lowest tertile of HOMA (P  .045).
Comment: The data are consistent with, and compliment, an addi-
tional recent study that detected abnormalities in carotid artery distension
and brachial artery reactivity in obese children (Lancet 2001;358:1400-4).
Increased traditional cardiovascular risk factors as well as alterations in blood
vessel mechanical properties induced by obesity may act in combination to
facilitate premature atherosclerosis in the obese.
The role of clinical examination in excluding vascular injury in hemo-
dynamically stable patients with gunshot wounds to the neck. A
prospective study of 59 patients
Mohammed GS, Pillay WR, Barker P, et al. Eur J Vasc Endovasc Surg
2004:28;425-30.
Conclusion: Even in stable patients with gunshot wounds to the neck,
physical examination is not a good predictor of vascular injury.
Summary:This was a study of 59 hemodynamically stable patients with
low-velocity gunshot wounds to the neck. Unstable patients and those with
obvious tracheal injury were excluded. Study patients underwent a clinical
examination according to a specific written protocol, and all underwent an
arch and four-vessel cerebral angiography. The study was conducted over 16
months in a regional trauma hospital in South Africa. Comparing physical
exam with angiography, the authors calculated sensitivity, specificity, and
predictive values of physical examination to predict vascular injury.
The injury site was in zone 2 in 26 patients, 11 of whom had vascular
injury. Seventeenpatients had zone1 entrywounds, and eight patients had zone
3 entrance wounds. In eight patients, the entrance wound was situated outside
the neck and two patients had more than one entrance wound. Twenty-six
patients had vascular injuries, and all but three were arterial injuries. The most
common vessel injured was the common carotid artery in 31%.
Of the 29 patients without physical examination signs of vascular
injury, 10 had evidence of vascular injury by angiography. Only 13 of 30
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